Biodisc and Viadisc are competing products in the degenerative disc space. Most surgeons will recognize Viadisc as it has managed to control a larger percentage of the market until recently. Biodisc is newer to the market, but gaining in popularity. Below are links to documents that highlight the stark scientific and clinical differences between the two.
Here’s a few reasons why BioDisc is also financially a better choice:
• BioDisc is not only far more effective, it costs thousands less per unit with no minimum order requirements.
• VIADISC is quickly losing coverage in most MACs because their formulation has changed and no longer reflects the study they originally relied on for reimbursement.
• BioDisc maintains solid reimbursement under CPT 0627T in most MAC regions and gaining traction with other carriers.
• We also provide:
✅ A written opinion from the AAPC, a nationally recognized Certified Professional Coding Agency.
✅ On-demand doctor-to-doctor protocol support
✅ Legal counsel with healthcare regulatory expertise available to assist

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.